EAST.H — EastWest Bioscience Balance Sheet
0.000.00%
Last trade - 00:00Consumer CyclicalsHighly SpeculativeMicro Cap
Annual balance sheet for EastWest Bioscience, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2020 July 31st | 2021 July 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash | ||
| Cash and Short Term Investments | 0.107 | 1.06 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 0.312 | 0.082 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 0.691 | 1.35 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 2.24 | 2.13 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Other Long Term Assets | ||
| Total Assets | 3.18 | 3.72 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 3.01 | 3.42 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Minority Interest | ||
| Total Liabilities | 3.23 | 4.16 |
| Common Stock | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | -0.046 | -0.439 |
| Total Liabilities & Shareholders' Equity | 3.18 | 3.72 |
| Total Common Shares Outstanding |